Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy

ConditionHemophilia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-65
SponsorUniversidad Católica San Antonio de Murcia

About this trial

Introduction. The development of hemophilic arthropathy causes degenerative joint damage that leads to functional impairment, limiting physical activity and causing disability in patients with hemophilia.

Objectives. i) To assess the level of physical activity in patients with hemophilia; ii) To identify the best predictive model for physical activity in adult patients with hemophilic arthropathy.

Material and method. Multicenter cross-sectional cohort study. Eighty-eight patients will be recruited. The dependent variable will be physical activity (International Physical Activity Questionnaire). Secondary variables will be kinesiophobia (Tampa Kinesiophobia Scale), functionality (Functional Independence Scale in Hemophilia), pain intensity, and clinical, anthropometric, and sociodemographic variables.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with hemophilia A or B

Over the age of majority

With a medical diagnosis of severe phenotype of the disease

With a medical diagnosis of hemophilic arthropathy in the lower limbs

Disqualifiers

Patients who require technical aids for walking

Patients who are dependent for activities of daily living

Patients over the age of 60

Patients with cognitive impairments that prevent them from understanding the questionnaires

Trial population

Patients with hemophilia A or B and hemophilic arthropathy where it is desired to assess the degree of physical activity and the main predictive factors for this.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Surveys

    Other intervention

    No intervention will be carried out in this study; the recruited patients will only complete the questionnaires provided below

Treatment groups

88 Participants
are divided into 1 treatment group
Group A: Observacional group1 intervention

Trial outcomes

Primary outcomes

1

Measurement of physical activity level

Physical activity levels will be assessed using the International Physical Activity Questionnaire (IPAQ). This tool assesses physical activity levels in adults aged 18 to 65. It consists of seven questions that ask about the frequency, duration, and intensity of physical activity performed in the last week. It also assesses the time spent walking and sitting. The results are classified into three categories: low, moderate, and high activity. The unit of measurement is metabolic equivalent task (METS), where a higher number of METS indicates greater physical activity.

Time frame
Screening visit

Secondary outcomes

1

Measurement of fear of movement

Fear of movement will be measured using the Tampa Kinesiophobia Scale (TSK). This self-reported questionnaire consists of 17 items, using a 4-point Likert scale. It comprises two subscales: avoidance of physical exertion due to fear of injury or pain, and belief that significant underlying medical problems exist. The total score ranges from 17 to 68 points, with a score of 37 or more indicating a high level of kinesiophobia

Time frame
Screening visit
2

Measurement of degree of functional independence

The degree of functional independence of patients will be measured using the Functional Independence Scale for Hemophilia (FISH). This tool measures eight activities of daily living: eating, personal hygiene, dressing, transferring from a chair, squatting, walking, climbing stairs, and running. Each activity is rated according to the level of assistance required, using a scale from 1 to 4. The total score can reach a maximum of 32 points, with a higher score indicating greater functional independence.

Time frame
Screening visit
3

Measurement of the joint pain

Pain intensity will be measured using the Visual Analog Scale (VAS). This is a simple and effective tool for measuring pain intensity. It consists of a horizontal line, usually 10 cm long, with one end representing "no pain" and the other "maximum pain imaginable."

Time frame
Screening visit
4

Measurement of age

The sociodemographic variable age will be measured in months completed from the date of birth

Time frame
Screening visit

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: